Sharp Financial Services’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$660K Sell
2,622
-99
-4% -$21.3K 0.31% 50
2026
Q1
$592K Buy
2,721
+544
+25% +$121K 0.29% 48
2025
Q4
$498K Buy
2,177
+201
+10% +$45.8K 0.25% 55
2025
Q3
$457K Sell
1,976
-148
-7% -$30.1K 0.25% 61
2025
Q2
$394K Buy
2,124
+110
+5% +$20.4K 0.25% 50
2025
Q1
$422K Buy
2,014
+836
+71% +$163K 0.32% 43
2024
Q4
$209K Sell
1,178
-128
-10% -$23.5K 0.16% 94
2024
Q3
$258K Sell
1,306
-90
-6% -$16.8K 0.2% 81
2024
Q2
$239K Buy
1,396
+2
+0.1% +$331 0.21% 85
2024
Q1
$254K Sell
1,394
-135
-9% -$23.3K 0.24% 75
2023
Q4
$237K Buy
+1,529
New +$223K 0.26% 75

Other funds holding ABBV

Sharp Financial Services's ABBV Position: Q2 2026 in Review

Sharp Financial Services reduced its AbbVie (ABBV) stake by 3.6% in Q2 2026, selling an estimated $21.3K and leaving 2,622 shares worth $660K. The position accounts for 0.31% of the portfolio, ranked #50.

Sharp Financial Services first reported a position in ABBV in Q4 2023 and has held it in 11 quarters since. 1,681 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Sharp Financial Services held 2,622 shares of AbbVie worth $660K as of Q2 2026.
  • Sharp Financial Services sold 99 AbbVie shares in Q2 2026, an estimated $21.3K.
  • AbbVie made up 0.31% of Sharp Financial Services's portfolio in Q2 2026, its #50 holding.
  • Sharp Financial Services first reported a position in AbbVie in Q4 2023 and has held it in 11 quarters since.
  • 1,681 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Sharp Financial Services's 13F filing for Q2 2026, filed 24 Jul 2026.